Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 301
Ph III recruiting: 41
Growth YoY: +4.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 1–20 of 20 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07642401	Large-scale Models of Esophageal Cancer and Related Research(DeepDT)	enrolling by invitation	—	12,000	The First Affiliated Hospital of Henan University of Science and TechnologyOTHER	1	Aug 27, 2026	clinicaltrials
NCT02427269	University of North Carolina (UNC) Barrett's Esophagus and Esophageal Cancer Biorepository(BEECAB)	enrolling by invitation	—	1,000	University of North Carolina, Chapel Hill